Hot Stock Analyst

  • Home
  • About
  • Blog
  • Market Conditions
Menu
January 4, 2021 Investing and Market Analysis No Comments

3 Biotech Stocks To Watch As 2021 Gets Underway

When it comes to the biotech stocks that experienced strong growth in 2020, the author of today’s article notes that the “more obvious cases such as vaccine company Moderna have […]

read more
December 17, 2020 Investing and Market Analysis No Comments

The Co-Managers Of An Outperforming Fund Share 3 Biotech Firms Poised To Solve Future Disease Outbreaks

The Shelton Green Alpha Fund is up more than 100% year-to-date and is among the best-performing funds of 2020 – and a big reason for its outperformance is its biotech […]

read more
November 28, 2020 Investing and Market Analysis No Comments

Blocking Cancer’s “Cloaking Signal” Creates A Massive Opportunity For This Biotech

With two innovative cancer treatment candidates that seek to block the “cloaking signal” used by cancer cells to trick the immune system into not attacking them, the small biotech highlighted […]

read more
October 11, 2020 Investing and Market Analysis No Comments

New Stocks To Watch In Biotech, Cleantech, Psychedelics & More

Today’s article highlights a plethora of new stocks to watch in the biotech, tech, cleantech, psychedelics and cannabis spaces, among others. In regards to the biotech names, the author notes […]

read more
September 11, 2020 Investing and Market Analysis No Comments

What Makes This Biotech An Attractive Investment Opportunity? An Impressive Brain Trust, A Supercomputer, The Third-Largest Biotech IPO In History – And More

Why might investors looking to get in on the next big biotech trend want to consider picking up shares of the company highlighted in today’s article? As the author explains, […]

read more
August 11, 2020 Investing and Market Analysis No Comments

An Overlooked Biotech With A Revolutionary Diabetes Drug Creates An Attractive Buying Opportunity

Since the discovery of insulin almost 100 years ago, there has been no novel therapy introduced for Type 1 diabetes. That could change in the coming months, however, if the […]

read more
July 5, 2020 Investing and Market Analysis No Comments

Its Diabetes-Delaying Drug Could Be A Game-Changer For This Under-The-Radar Biotech

What makes the clinical-stage biotech highlighted in today’s article, one focused on developing drugs to prevent certain diseases, worth strongly considering? Its most exciting drug candidate seeks to delay the […]

read more
June 15, 2020 Investing and Market Analysis No Comments

Better Pick A COVID-19 Vaccine Play

When it comes to which of the two biotech stocks with COVID-19 vaccine candidates focused on in today’s article is the better pick going forward, especially for aggressive investors, the […]

read more
May 6, 2020 Investing and Market Analysis No Comments

Remdesivir’s COVID-19 Success Could Create A Big “Piggyback” Opportunity For This Under-The-Radar Biotech

There is currently only one drug that has demonstrated the potential to be a safe and effective treatment for COVID-19 in clinical trials: Gilead Sciences’ remdesivir. Today’s article, however, highlights […]

read more
January 31, 2020 Investing and Market Analysis No Comments

These Biotechs Are Surging Along With Coronavirus Infections

As the number of cases of infection by the novel coronavirus around the world rises, so are shares of a number of biotech companies with exposure to experimental vaccines (as […]

read more
1 2 Next »

Free Report

Archives

Legals

  • DATA USE POLICY
  • TERMS OF USE
  • Disclaimer
  • PRIVACY POLICY
  • Contact US

Legals

  • DATA USE POLICY
  • TERMS OF USE
  • Disclaimer
  • PRIVACY POLICY
  • Contact US

Free Report

Hot Stock Analyst – Financial Newsletters, Stock Research and More